|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2011-5-20
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
The optimal time to initiate antiretroviral therapy (ART) in human immunodeficiency virus (HIV)-associated tuberculous meningitis is unknown.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1537-6591
|
|
pubmed:author |
pubmed-author:AnhDo Thi Tuongdo TT,
pubmed-author:BangNguyen DucND,
pubmed-author:ChauNguyen Van VinhNV,
pubmed-author:ChauTran Thi HongTT,
pubmed-author:ChinhNguyen TranNT,
pubmed-author:DungNguyen HuyNH,
pubmed-author:DungNguyen ThiNT,
pubmed-author:FarrarJeremy JamesJJ,
pubmed-author:HaiNguyen NgocNN,
pubmed-author:HienNguyen QuangNQ,
pubmed-author:HienTran TinhTT,
pubmed-author:IrwinMichael GarnetMG,
pubmed-author:LanNguyen NgocNN,
pubmed-author:LanNguyen Thi NgocNT,
pubmed-author:MaiNguyen Thi HoangNT,
pubmed-author:MaiPham PhuongPP,
pubmed-author:MingN GNG,
pubmed-author:PhuNguyen HoanNH,
pubmed-author:QuyHoang ThiHT,
pubmed-author:TörökM EsteeME,
pubmed-author:ThaiPhan Vuong KhacPV,
pubmed-author:ThoaNguyen Thi CamNT,
pubmed-author:TienNguyen AnhNA,
pubmed-author:WolbersMarcelM,
pubmed-author:XUTingT,
pubmed-author:YenNguyen Thi BichNT,
pubmed-author:de JongMennoM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1374-83
|
|
pubmed:meshHeading |
pubmed-meshheading:21596680-Adult,
pubmed-meshheading:21596680-Anti-HIV Agents,
pubmed-meshheading:21596680-Anti-Inflammatory Agents,
pubmed-meshheading:21596680-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:21596680-Antitubercular Agents,
pubmed-meshheading:21596680-Benzoxazines,
pubmed-meshheading:21596680-Dexamethasone,
pubmed-meshheading:21596680-Double-Blind Method,
pubmed-meshheading:21596680-Female,
pubmed-meshheading:21596680-HIV Infections,
pubmed-meshheading:21596680-Humans,
pubmed-meshheading:21596680-Lamivudine,
pubmed-meshheading:21596680-Male,
pubmed-meshheading:21596680-Placebos,
pubmed-meshheading:21596680-Time Factors,
pubmed-meshheading:21596680-Treatment Outcome,
pubmed-meshheading:21596680-Trimethoprim-Sulfamethoxazole Combination,
pubmed-meshheading:21596680-Tuberculosis, Meningeal,
pubmed-meshheading:21596680-Zidovudine
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.
|
|
pubmed:affiliation |
Department of Infectious Diseases, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, United Kingdom. estee.torok@addenbrookes.nhs.uk
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
